Asensus Surgical, Inc.

TransEnterix Inc. , which markets the Senhance Surgical Robotic System, appointed Shameze Rampertab as its new chief financial officer, effective 24 August, the company announced on 13 August. Rampert

“Digital is no longer a vertical, it cuts across all sectors. It is a horizontal.” Andy Fish, AdvaMed's chief strategy officer, was telling the press in late fall 2019 that medtech companies will come

The combined market for prostate cancer diagnostics and minimally invasive treatments is set to increase from $900m to $1.46bn in the next five years. But conservative treatment, or watchful waiting,

The global market for endoscopic surgery and pelvic surgery procedures is expected to grow at a compound annual growth rate (CAGR) of 6.4% to reach $17.7bn in 2023, according to " General and Pelvic E